Concepedia

Kameswaran Ravichandran

KR

21

Publications

955

Citations

17

H-Index

2010

Active since

Affiliations

University of Colorado Denver(Current)

University Hospital Dubrava

Ionis Pharmaceuticals (United States)

University of Colorado Cancer Center

University of Zagreb

Kameswaran Ravichandran is an author at University of Colorado Denver specializing in medicine, renal inflammation, and immunology.

ORCID

Top concepts

Publications per year

2010–2021

21

Publications

21

NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury

Hyun Jung Kim, Dong Won Lee, Kameswaran Ravichandran et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 134 citations · Full text

NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI)

Abdullah Özkök, Kameswaran Ravichandran, Qian Wang et al. · Toxicology Letters · 2015 · 105 citations

, , +6

Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease

Iram Zafar, Kameswaran Ravichandran, Franck A. Belibi et al. · Kidney International · 2010 · 101 citations · Full text

, , +10

Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD)

Franck A. Belibi, Iram Zafar, Kameswaran Ravichandran et al. · American Journal of Physiology-Renal Physiology · 2011 · 100 citations · Full text

Inhibitory Effect of Silibinin against Azoxymethane-Induced Colon Tumorigenesis in A/J Mice

Kameswaran Ravichandran, Velmurugan Balaiya, Mallikarjuna Gu et al. · Clinical Cancer Research · 2010 · 64 citations · Full text

Rows per page

1–5 of 21